Company intelligence / Profile preview

Gastro Health

Birmingham, Alabama, United States

Ownership: Private
Development stage: Other

Overview

Gastro Health conducts and supports clinical trials for FDA-approved and investigational drugs in gastrointestinal and hepatological diseases; as an operator, not drug developer, clinical results pertain to patient outcomes in its network and contributions to multicenter trials, not product approvals

Therapeutic areas: OncologyGastroenterologyInfectious DiseasesImmunology
Modalities: Small moleculeBiologicDeviceAI-enabled diagnostics
Industry: Non-Academic Healthcare

Partnerships

Iterative Health (AI-enabled pathology and diagnostics technology for GI)Lynx.MD (cloud-based health data platform)

Beyond the preview

Go deeper on Gastro Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastro Health.

Explore the full profile